Editorial Comment

Urology

Volumn 75, Issue 6, 2010, Pages 1371-

  Kattan, Michael W ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER STAGING; HIGH RISK PATIENT; HUMAN; KIDNEY CARCINOMA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOTE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; UCLA INTEGRATED STAGING SYSTEM;

CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 77952738288     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.07.1288     Document Type: Note

References (4)

1. Tan M.-H., Kanesvaran R., Li H., et al. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Urology 75 6 (2010) 1365-1370
2. Cindolo L., Patard J., Chiodini P., et al. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy. Cancer 104 7 (2005) 1362-1371
3. Eastham J.A., Kelly W.K., Grossfeld G., et al. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease. Urology 62 suppl 6B (2004) 55-62
4. Eisenberger M. Treatment of prostate cancer in the 21st century-future directions. Eur Urol suppl 5 (2006) 824-829